scientific-skills/Evidence Insights/blockbuster-therapy-predictor/SKILL.md
Comprehensive analytics tool for forecasting breakthrough therapeutic technologies by integrating multi-dimensional data sources including clinical development pipelines, intellectual property landscapes, and capital mar.
npx skillsauth add aipoch/medical-research-skills blockbuster-therapy-predictorInstall this skill globally with one command. Works with Claude Code, Cursor, and Windsurf.
4 of 9 scanners reported clean
Some scanners were skipped, did not run, or reported a non-clean status. Review each row below.
Comprehensive analytics tool for forecasting breakthrough therapeutic technologies by integrating multi-dimensional data sources including clinical development pipelines, intellectual property landscapes, and capital market indicators.
See ## Features above for related details.
scripts/main.py.references/ for task-specific guidance.See ## Usage above for related details.
cd "20260318/scientific-skills/Evidence Insight/blockbuster-therapy-predictor"
python -m py_compile scripts/main.py
python scripts/main.py --help
Example run plan:
CONFIG block or documented parameters if the script uses fixed settings.python scripts/main.py with the validated inputs.See ## Workflow above for related details.
scripts/main.py.references/ contains supporting rules, prompts, or checklists.Use this command to verify that the packaged script entry point can be parsed before deeper execution.
python -m py_compile scripts/main.py
Use these concrete commands for validation. They are intentionally self-contained and avoid placeholder paths.
python -m py_compile scripts/main.py
python scripts/main.py --help
# Run complete analysis with all technologies
python scripts/main.py
# Analyze specific technologies
python scripts/main.py --tech PROTAC,mRNA,CRISPR
# Output in JSON format
python scripts/main.py --output json
| Parameter | Type | Default | Required | Description |
|-----------|------|---------|----------|-------------|
| --mode | str | full | No | Analysis mode: full or quick |
| --tech | str | None | No | Comma-separated list of technologies to analyze |
| --output | str | console | No | Output format: console or json |
| --threshold | float | 0 | No | Minimum blockbuster index threshold (0-100) |
| --save | str | None | No | Save report to file path |
# Analyze high-potential technologies only (index ≥70)
python scripts/main.py \
--threshold 70 \
--output json \
--save high_potential_report.json
# Quick analysis of specific platforms
python scripts/main.py \
--mode quick \
--tech CAR-T,ADC,Bispecific \
--output console
🏆 BLOCKBUSTER THERAPY PREDICTOR Report
Generated: 2026-02-15 10:30:00
Technologies analyzed: 10
📊 Technology Rankings
Rank Technology Blockbuster Index Maturity Market Potential Momentum Recommendation
🥇 1 mRNA 85.2 78.5 92.1 88.0 Strongly Recommended
🥈 2 CAR-T 82.3 85.2 78.5 75.0 Strongly Recommended
🥉 3 CRISPR 79.8 72.3 88.2 68.0 Recommended
{
"generated_at": "2026-02-15T10:30:00",
"total_routes": 10,
"rankings": [
{
"rank": 1,
"tech_name": "mRNA",
"blockbuster_index": 85.2,
"maturity_score": 78.5,
"market_potential_score": 92.1,
"momentum_score": 88.0,
"recommendation": "Strongly Recommended",
"key_drivers": ["Multiple Phase III trials", "Rapid patent growth"],
"risk_factors": ["Regulatory uncertainties"],
"timeline_prediction": "First product expected in 2-4 years"
}
]
}
Blockbuster Index = (Market Potential × 0.5) + (Maturity × 0.3) + (Momentum × 0.2)
| Component | Weight | Factors | |-----------|--------|---------| | Market Potential | 50% | Market size, unmet need, competition | | Maturity | 30% | Clinical stage, patent depth, funding stage | | Momentum | 20% | Patent growth, funding activity, clinical progress |
| Blockbuster Index | Recommendation | Action | |-------------------|----------------|--------| | ≥ 80 | Strongly Recommended | Prioritize R&D investment | | 60-79 | Recommended | Active monitoring and early partnerships | | 40-59 | Watch | Monitor milestones; reassess in 6-12 months | | < 40 | Cautious | Minimal investment; consider divestment |
| Technology | Category | Description | |------------|----------|-------------| | PROTAC | Protein Degradation | Proteolysis Targeting Chimera | | mRNA | Nucleic Acid Drugs | Messenger RNA therapy platform | | CRISPR | Gene Editing | CRISPR-Cas gene editing technology | | CAR-T | Cell Therapy | Chimeric Antigen Receptor T-cell therapy | | Bispecific | Antibody Drugs | Bispecific antibody technology | | ADC | Antibody Drugs | Antibody-Drug Conjugate | | RNAi | Nucleic Acid Drugs | RNA interference therapy | | Gene Therapy | Gene Therapy | AAV vector gene therapy | | Allogeneic | Cell Therapy | Universal/Allogeneic cell therapy | | Cell Therapy | Cell Therapy | General cell therapy platform |
⚠️ AI independent acceptance status: manual inspection required This skill requires:
pip install -r requirements.txt
dataclasses
enum
| Risk Indicator | Assessment | Level | |----------------|------------|-------| | Code Execution | Python scripts executed locally | Medium | | Network Access | No external API calls in mock mode | Low | | File System Access | Read/write report files only | Low | | Instruction Tampering | Standard prompt guidelines | Low | | Data Exposure | Output files saved to workspace | Low |
# Python dependencies
pip install -r requirements.txt
See references/ for:
⚠️ DISCLAIMER: This tool provides quantitative analysis for decision support only. All investment and R&D decisions should incorporate qualitative domain expertise, regulatory consultation, and comprehensive due diligence. Past performance of historical blockbusters does not guarantee future success of emerging technologies.
Every final response should make these items explicit when they are relevant:
scripts/main.py fails, report the failure point, summarize what still can be completed safely, and provide a manual fallback.This skill accepts requests that match the documented purpose of blockbuster-therapy-predictor and include enough context to complete the workflow safely.
Do not continue the workflow when the request is out of scope, missing a critical input, or would require unsupported assumptions. Instead respond:
blockbuster-therapy-predictoronly handles its documented workflow. Please provide the missing required inputs or switch to a more suitable skill.
Use the following fixed structure for non-trivial requests:
If the request is simple, you may compress the structure, but still keep assumptions and limits explicit when they affect correctness.
tools
Generates complete conventional oncology bulk-transcriptome biomarker and hub-gene research designs from a user-provided cancer type and study direction. Always use this skill whenever a user wants to design, plan, or build a tumor bioinformatics study centered on differential expression, prognostic filtering or risk modeling, PPI-based hub-gene prioritization, diagnostic/prognostic evaluation, clinical association, immune infiltration context, methylation context, and optional tissue or cell validation. Covers five study patterns (signature-first prognostic workflow, hub-gene-first biomarker workflow, hybrid signature-to-hub workflow, immune-context biomarker workflow, translational validation workflow) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with recommended primary plan, step-by-step workflow, figure plan, validation strategy, minimal executable version, publication upgrade path...
development
Generates complete conventional non-oncology bioinformatics research designs from a user-provided disease context, process-related gene family or biological theme, and validation direction. Use when a study centers on multi-dataset bulk transcriptome integration, DEG analysis, process-gene intersection, enrichment analysis, GSEA, PPI hub-gene prioritization, TF/miRNA regulatory networks, ROC-based biomarker evaluation, and immune infiltration analysis. Covers five study patterns (process-DEG discovery, enrichment/GSEA interpretation, hub-gene prioritization, regulatory-network and immune interpretation, multi-layer public validation) and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.
tools
Plans confounder control, variable adjustment logic, and bias mitigation strategies at the protocol stage for clinical, epidemiologic, translational, observational, and biomarker studies. Always use this skill when a user needs to identify major confounders, decide which variables should or should not be adjusted for, compare matching/stratification/weighting approaches, anticipate selection or measurement bias, or pressure-test a study design before execution. Focus on bias sensing, causal structure awareness, variable-role classification, and critical design review rather than generic statistical advice.
testing
Generates complete comparative network-toxicology research designs from a user-provided exposure pair, shared toxic phenotype, and validation direction. Use when a study centers on two related exposures under one outcome and needs target collection, shared-vs-specific target decomposition, enrichment, PPI hub prioritization, docking, optional transcriptomic cross-checks, and conservative mechanistic synthesis. Covers five study patterns and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.